H1N1 Vaccines Locations - Los Angeles, CA

NEWS:  Studies investigate the link between

                       HVAC and Disease.
When public officials are deciding what steps to take against the second wave of the H1N1 virus, known as the swine flu, new information is available between airborne diseases and the our building's central air and heating systems.

The new report from the American Society of Heating, Refrigeration and air conditioning engineers (ASHREA), Infectious Disease Position Document, implies that ventilation is a main vector of diseases transmission.

Known information about influenza transmission usually occurs through droplet transmission or direct contact. New data suggest that influenza transmission occurs through an airborne route, implicating HVAC systems. 

ASHREAS goal of this following document is to use health science, combined with engineering practices and principals to identify how changes can be made in the HVAC system to prevent the transmission of the disease through the air.

The three known methods of transmission are large droplet nuclei (>10M), direct contact and smaller droplet nuclei (<10m).  Personal hygiene, using handkerchiefs or masks, has been a direct control strategy for the coughing and sneezing that produces droplet nuclei CDC 2001.  The known dispersion patterns a cough or sneeze may also travel through the airborne route, as data suggest, HVAC systems may contribute to disease transmission.

Ventilation represents a primary infectious disease control strategy through dilution of room air around a source (CDC 2005). 

Solutions of interest include; dilution ventilation, differential room pressurization, room flow regimes, source capture, filtration, UV irradiation, or source capture ventilation.

Directed supply and / or exhaust ventilation such as laminar flow and displacement is important in several settings including operating rooms (AIA 2006).

LEFT Picture - Vent cover,HVAC. H1N1 Flu Virus
 



IAQ RADIO: Episode#143; H1N1 Virus; Fact Vs. Fiction
The information provided on this one hour long "ask the doctor" questionnaire can answer many questions you have about the H1N1 virus.  Basic and advanced information is presented by the physician about viruses, transmission of viruses and current CDC methods used to track the H1N1 virus.  During the broadcast the announcers Cliff "Z Man" Zlotnik, Joe "Radio Joe" Hughes really helped the doctor layout as much information as possible.  To listen to the show please click the radio or the page link below.
http://www.iaqradio.com/
 


H1N1 Vaccinations at the following CVS Locations
Inside CVS/Pharmacy #9751
5623 Kanan Road
Agoura, CA 91301

Inside CVS/pharmacy #9576
10889 Wellworth Avenue
Los Angeles, CA 90024

Inside CVS/pharmacy #9615
19353 Victory Boulevard
Reseda, CA 91335

Inside CVS/pharmacy #8871
13171 Mindanao Way
Marina Del Rey, CA 90292

 Note: Currently, the demand for H1N1 vaccine is outweighing local and national supply. That’s why some Public Health vaccine clinics may reach capacity earlier than expected and need to close earlier than the posted hours. If you are not in an H1N1 Priority Group, please wait to get vaccinated until vaccine supplies increase. More H1N1 vaccine will be available in the next several days and weeks at some chain pharmacies, private health care providers, and community clinics.sewage back up or broken pipe. Determining if sewage contamination has occurred is a prime public health concern. Some of the potentially harm organism are E.Coli, Shigella, and Salmonella. As these organism are usually found in low numbers in sewage, other more common types of bacteria have been used as primary indicators. In the past, those organisms are typically coliforms and tota fecal coliforms. These samples were originally used to test clean water samples and are now used to test for bacterial contamination.

H1N1 Facts - www.FunGuyInspections/H1N1-Facts.com
 



  EDUCATION:       H1N1: Preparedness, Contingency Planning, and Tips for Auditing

The Auditing Roundtable and AIHA are pleased to co-present "H1N1: Preparedness, Contingency Planning, and Tips for Auditors." This one-hour webinar will provide brief background on H1N1 -- what it is, and why it's different. It will focus on business issues, preparedness and contingency plans, testing of plans, safety and industrial hygiene tips, resources, and tips on how EHS Auditors can convey useful information and help manage safety and business risks.

Mr. Steve Motzko, CSP, manager of EHS at Simpson Strong-Tie and Tom Fuller, ScD, CIH, MSPH, MBA and Program Director of Environmental Health Science at Illinois State University will be our presenters. Both gentlemen have presented on this topic to the Auditing Roundtable and/or AIHA before, to great acclaim.
Pricing: $60 to the general public, $50 for members of organizations affiliated with the Auditing Roundtable, $40 for Auditing Roundtable or AIHA members. Registration at www.auditing-roundtable.org.

Contact kathy@auditing-roundtable.org  for pricing information if you are a government employee, in academia full time, a nonprofit entity, or are currently unemployed.

Attendees on December 14 will receive 1 CEU credit on successful completion of a short quiz within two weeks of the session.

The webinar will be available for replay at least through March 31, 2009, at www.auditing-roundtable.org.